As the coronavirus that causes COVID-19 spreads in more than 60 countries, the race to develop a vaccine to prevent the illness has taken on new urgency. In a meeting with CEOs of major drug companies this week, President Trump ramped up the pressure, suggesting that vaccines could come to...
accessibility
affordability
coronavirus
covid-19
drug companies
equity
global health
health
healthcare policy
pharmaceuticals
public health
research
social justice
taxpayer funding
trump administration
u.s. government
urgency
vaccinevaccinedevelopment
The first human trial of an experimental vaccine against Ebola suggests that it is safe and may help the immune system to combat the virus.
Twenty volunteers were immunised in the United States. Scientists at the US National Institutes of Health (NIH) described the results as "promising".
The...
antibodies
clinical trial
dr fauci
ebola
health
human trial
immune system
immunization
infection
nih
phase one
promising
research
results
safety
scientific study
side effects
vaccinevaccinedevelopment
volunteers